Video Experimental Relacionado
Updated: Feb 27, 2026

13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
12.3K
Desarrollo y Validación Técnica del Panel CLEARS (Clinical Lymphoma Exploration and Research Sequencing) y su
Iva Hamová1,2, Adriana Velasová1, Petra Zemánková3
1BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.
Folia biologica
|February 25, 2026
Resumen
No abstract available in PubMed .
Palabras clave:
Linfoma no HodgkinLinfoma de HodgkinADN tumoral circulantebiopsia líquidalinfomasecuenciación de ADN de próxima generaciónB-NHLT-NHLCAPP-SeqCLEARSHLNHLctDNA
